Warning letter
ABCO Laboratories, Inc.: warning letter of Jun 19, 2012
FDA warning letter 267762 · San Francisco District Office
Key facts
| Reference number | 267762 |
|---|---|
| Company | ABCO Laboratories, Inc. |
| Subject | Dietary Supplement/Promotional Claims False & Misleading/Adulterated/Misbranded |
| Issue date | Jun 19, 2012 |
| Posted date | Jun 19, 2012 |
| Issuing office | San Francisco District Office |
| Product type | Drugs |
| CFR sections cited | 201.5 |
| Inspection city | Fairfield |
| Inspection ZIP | 94533 |
| Inspection start date | Aug 26, 2011 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: